Home | Contact Us

Roskamp Institute Patients, Families and Friends Healthcare Professionals Clinical Operations
Roskamp Institute
About Us How to Help News Careers PhD Program Better science. Real discovery.

 

2013 Society for Neuroscience Conference
November 9-13, San Diego, CA

Poster/Symposium Presentations By Roskamp Institute Scientists

Title (Click for Abstracts)Author(s)/Affiliations
Characterization of neurobehavioral, neuropathological and proteomic profiles in a novel animal model of co-morbid posttraumatic stress disorder and mild traumatic brain injury*J. O. OJO1, M. GREENBERG1, J. REED1, G. CRYNEN1, S. FERGUSON1,2, B. MOUZON1,2, C. BACHMEIER1,2, D. DIAMOND3,2, M. MULLAN1,2, F. CRAWFORD1,2;

1The Roskamp Inst., Sarasota, FL; 2James A Haley Veterans Hosp., Tampa, FL; 3Univ. of South Florida, Tampa, FL
Influence of apolipoprotein E on lipoprotein receptor function *B. SHACKLETON, M. MULLAN, F. CRAWFORD, C. BACHMEIER;

Roskamp Inst., Sarasota, FL
Use of lipidomics to identify novel blood phospholipid biomarkers that detect Mild Cognitive Impairment and early Alzheimer's disease
*L. ABDULLAH, J. EVANS, H. MONTAGUE, A. GONZALEZ, A. SHAH, B. KIRK, J. M. REED, G. CRYNEN, R. PELOT, C. LUIS, A. P. KEEGAN, M. MULLAN, F. CRAWFORD;

Roskamp Inst., SARASOTA, FL
Omic profiling identifies distinct protein and lipid biomarker profiles correlating with diagnoses of TBI and PTSD in a deployed military population
*T. E. EMMERICH1, G. CRYNEN1, L. ABDULLAH1, J. REED1, J. EVANS1, H. MONTAGUE1, A. HART1, A. GONZALEZ1, A. BISHOP1, B. MOUZON1, S. FERGUSON1, R. PELOT1, M. MULLAN1, M. DRETSCH2, F. CRAWFORD1;

1Roskamp Inst., Sarasota, FL; 2Dept. of the Army, Arlington, VA
Longitudinal characterization of neurobehavioral and neuropathological outcomes in young hTau transgenic mice after single or repetitive mild traumatic brain injury*B. C. MOUZON1,2,3, J. OLUBUNMI1, A. FERRO1, G. CRYNEN1,3, C. BACHMEIER1,2,3, C. ACKER4, P. DAVIE5, M. MULLAN1,2,3, W. STEWART6,7, F. CRAWFORD1;

1The Roskamp Inst., Sarasota, FL; 2James A. Haley Veterans'
 Hosp., Tampa, FL; 3The Open Univ., Milton Keynes, United Kingdom; 4Dept. of Pathology, Albert Einstein Col. of Med., Bronx, NY; 5Litwin-Zucker Ctr. for Res. in Alzheimer's Dis., Feinstein Inst. for Med. Res., Manhasset, NY; 6Dept. of Neuropathology, Southern Gen. Hosp., Glasgow, United Kingdom; 7Univ. of Glasgow, Glasgow, United Kingdom
Treatment with anatabine significantly improves chronic outcome in a mouse model of repetitive mild TBI*S. FERGUSON, B. MOUZON, L. ABDULLAH, G. CRYNEN, M. MULLAN, V. MATHURA, M. MULLAN, F. CRAWFORD;

Roskamp Inst., Sarasota, FL
Investigating the relationship between cognitive impairment and the inflammatory responses following exposure to gulf war agents at early and late time points using a mouse model of GWI *Z. ZAKIROVA1,2, M. TWEED1,2, G. CRYNEN1, J. REED1, L. ABDULLAH1,2, F. CRAWFORD1, M. MULLAN1, V. MATHURA1, G. AIT-GHEZALA1;

1Roskamp Inst., Sarasota, FL; 2The Open Univ., Milton Keynes, United Kingdom
Investigation of constitutive CD40 signaling of tau post translation modifications
*M. TWEED1,2, Z. ZAKIROVA1,2, C.-H. VOLMAR3, J. FRIELING4, M. MULLAN1, M. MULLAN1,2, G. AIT-GHEZALA1,2;

1Roskamp Inst., Sarasota, FL; 2James A. Haley Veterans'
 Hosp., Tampa, FL; 3Hussman Inst. for Human Genomics, Ctr. for Therapeut. Innovation (CTI) Univ. of Miami Miller Sch. of Med., Miami, FL; 4Dept. of Tumor Biology,, H. Lee Moffitt Cancer Ctr. and Res. Institute,, Tampa, FL
Behavioral effects of anatabine in wild-type and transgenic mouse models of Alzheimer's disease*M. VERMA, D. BEAULIEU-ABDELAHAD, F. CRAWFORD, M. MULLAN, D. PARIS;

Roskamp Inst., Sarasota, FL


Top | Home